Latest News & Features
Big Pharma
US Senate committee accuses drug companies of ‘gaming’ the patent system | Industry representatives interrogated during hearing | ‘Playing games with patents has to stop’, says one Senator. 23 May 2024
Careers
The patent attorney’s expertise spans artificial intelligence, machine learning and medical devices. 23 May 2024
Biotechnology
New Jersey federal judge said Acuitas had failed to show case or controversy | Acuitas had sought declaratory judgment that Pfizer’s Comirnaty vaccine did not infringe patents. 23 May 2024
Biotechnology
ARP maintained rejection of two claims of Xencor’s antibodies patent application | Panel clarified specification for means-plus-function claim limitations. 21 May 2024
Biotechnology
Despite attempts by Pfizer and BioNTech to invalidate the patent, the ruling strengthens Moderna’s position in ongoing global litigation | Pfizer is considering an appeal, while BioNTech remains steadfast in defending its innovations. 21 May 2024
Careers
Experienced patent attorney represents clients in a wide range of industries, including renewable energy, semiconductors and artificial intelligence. 21 May 2024
Europe
As the company challenges Pfizer and BioNTech over COVID-19 vaccine patents, issues over the enforceability of pledges made during the pandemic may make pharma think twice in future, finds Marisa Woutersen. 16 May 2024
Careers
Firm adds counsel to IP department in Boston office | Ex-senior patent attorney at Novartis brings broad range of life sciences experience. 16 May 2024
Biotechnology
Puritan Medical argued it had immunity under PREP Act in patent suit | Fed Circ said the district court had not conclusively determined any issue. 16 May 2024
Americas
An LSPN panel discusses the challenges and strategies for effective collaboration between in-house counsel and outside legal teams, stressing the importance of communication, strategic planning, and clear expectations. 14 May 2024